Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate ...

A breakthrough in cancer treatment has emerged from a multi-institutional study led by the Moffitt Cancer Center in Florida, ...

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic ...

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to ...

which is isolated with a series of catheters and balloons via percutaneous insertions. The chemotherapy is filtered out before it gets introduced to the rest of the body. This targeted approach helps ...

Boston Scientific Corporation ( NYSE: BSX) Q1 2025 Results Conference Call April 23, 2025 8:00 AM ET Jon Monson - Senior Vice President, Investor Relations Mike Mahoney - Chairman and Chief Executive ...

“Another one of my cousins, he’s getting a port now,” Mark said, referring to the under-skin catheters used in ... some indication of AFFF’s toxic effects decades before such information ...

This excerpt comes from the forthcoming book “Poisoning the Well: How Forever Chemicals Contaminated America,” which details how a set of toxic compounds have devastated entire communities across the ...